Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus

被引:25
作者
Gnann, JW
Pellett, PE
Jaffe, HW
机构
[1] Univ Alabama, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
D O I
10.1086/313841
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human herpesvirus 8 (HHV-8) was detected in 1994 in biopsies of Kaposi's sarcoma (KS) tissues from a patient with AIDS, The evidence that HHV-8 infection is etiologically related to the development of KS is compelling, Essentially all patients with KS of any epidemiological type have serological evidence of HHV-8 infection. About 30%-40% of homosexual men infected with human immunodeficiency virus (HIV) are seropositive for HHV-8; rates are lower (<10%) among HIV-infected women, hemophiliacs, and injection drug users. Among homosexual men, the probability of HHV-8-seropositivity is directly proportional to the numbers of previous male sex partners, which suggets that HHV-8 is a sexually transmitted infection, Although HHV-8 is detectable in saliva and semen, the exact mechanism of transmission is not known. A reduction in KS incidence among patients with AIDS in the 1980s has been attributed to lower rates of HHV-8 transmission that resulted from alterations in sexual behaviors. A further decline in KS incidence has been associated with the use of antiretroviral therapy. Antiretroviral therapy to control HIV replication and to limit the associated immunodeficiency is currently the best approach for preventing KS in persons infected with HHV-8 and HIV.
引用
收藏
页码:S72 / S76
页数:5
相关论文
共 68 条
[41]   Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma [J].
Lebbé, C ;
Blum, L ;
Pellet, C ;
Blanchard, G ;
Vérola, O ;
Morel, P ;
Danne, O ;
Calvo, F .
AIDS, 1998, 12 (07) :F45-F49
[42]   Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion [J].
Lefrere, JJ ;
Meyohas, MC ;
Mariotti, M ;
Meynard, JL ;
Thauvin, M ;
Frottier, J .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (02) :283-287
[43]   Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients [J].
Lennette, ET ;
Blackbourn, DJ ;
Levy, JA .
LANCET, 1996, 348 (9031) :858-861
[44]   KAPOSIS SARCOMA IN A COHORT OF HOMOSEXUAL AND BISEXUAL MEN - EPIDEMIOLOGY AND ANALYSIS FOR COFACTORS [J].
LIFSON, AR ;
DARROW, WW ;
HESSOL, NA ;
OMALLEY, PM ;
BARNHART, JL ;
JAFFE, HW ;
RUTHERFORD, GW .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 131 (02) :221-231
[45]  
LOW P, 1999, 6 C RETR OPP INF AL
[46]   Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant [J].
Martin, DF ;
Kuppermann, BD ;
Wolitz, RA ;
Palestine, AG ;
Li, H ;
Robinson, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (14) :1063-1070
[47]   Sexual transmission and the natural history of human herpesvirus 8 infection [J].
Martin, JN ;
Ganem, DE ;
Osmond, DH ;
Page-Shafer, KA ;
Macrae, D ;
Kedes, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (14) :948-954
[48]  
Melbye M, 1998, INT J CANCER, V77, P543, DOI 10.1002/(SICI)1097-0215(19980812)77:4&lt
[49]  
543::AID-IJC12&gt
[50]  
3.0.CO